The European Commission published legislative proposals on October 20, 2011 as part of its review of the existing European Markets in Financial Instruments Directive (MiFID). The draft legislation includes rules on trading platforms, transparency and investor protection.
The overarching objective of the original MiFID framework was to further the integration, competitiveness and efficiency of European financial markets. ISDA supports changes that build on that goal, including the introduction of an effective post-trade transparency regime for OTC derivatives.
On this page you can find materials that set out ISDA’s position on the MiFID review. To listen to recent Member Calls on the directive, login to the Members Portal here.
ISDA is also closely involved in the work of the Joint Associations Committee on Retail Structured Products (JAC), which is following the elements of the MiFID Review that impact on the market for retail structured products. Please see: http://www2.isda.org/asset-classes/structured-products
Latest
ISDA Wins Regulation Asia Award
ISDA has been awarded Outstanding Contribution to Regulatory Reforms for the ISDA Digital Regulatory Reporting (ISDA DRR) solution by Regulation Asia at its ninth annual Awards for Excellence. The ISDA DRR uses the Common Domain Model to convert an industry-agreed...
ISDA Launches RFP for Trade Eligibility Solution
ISDA has launched a request for proposal (RFP) for the development of a trade reporting eligibility tool for use alongside the ISDA Digital Regulatory Reporting (DRR) solution. The eligibility tool is intended to provide analysis on whether a derivatives transaction...
Joint Response to ETS Review
On November 2, ISDA and the Association for Financial Markets in Europe submitted a joint statement on the European Commission’s call for feedback on the review of the EU Emissions Trading System (ETS). The response highlights the importance of a...
Updated OTC Derivatives Compliance Calendar
ISDA has updated its global calendar of compliance deadlines and regulatory dates for the over-the-counter (OTC) derivatives space.